Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMH9EUA)

Drug Name
Nemolizumab Drug Info
Indication
Disease Entry ICD 11 Status REF
Atopic dermatitis EA80 Phase 3 [1]
Cross-matching ID
TTD Drug ID
DMH9EUA

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas
Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Interleukin 31 receptor (IL31R) TT9HPX0 IL31R_HUMAN Not Available [2]

References

1 ClinicalTrials.gov (NCT03989206) Long-term Safety and Efficacy of Nemolizumab With Moderate-to-severe Atopic Dermatitis. U.S. National Institutes of Health.
2 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)